Another Study Shows Strong Link Between Cholesterol-lowering Statin Drugs and Diabetes

Another study has confirmed that statin drug use increases one's chance of developing diabetes. Statin drugs are the all-time leading prescription drugs sold in the U.S. and around the world, prescribed by doctors to lower people's cholesterol levels. It is estimated that one out of every 4 people in the United States over the age of 50 is currently taking statin drugs for cholesterol. This current study just published looked at 26,000 beneficiaries of Tricare, the military health system. They found that those taking statin drugs to control their cholesterol were 87 percent more likely to develop diabetes. The study was published in the Journal of General Internal Medicine. This just the latest study to link statin drugs to diabetes, especially in women. Studies published in 2014 caused over 2000 lawsuits to be filed against Pfizer, the maker of the best-selling drug of all-time, Lipitor.

Dr. Brownstein: National Panel Reverses Idiotic Cholesterol Guidelines

As reported in the New York Times (2.20.15), a nutrition advisory panel that shapes U.S dietary advice eased some of the previous restrictions on fat and cholesterol, while at the same time recommending Americans lower their consumption of sugar. For many years, I have been writing and lecturing about the idiotic cholesterol and fat guidelines that the Powers-That-Be have been espousing. Over 30 years ago, we were told to eat less fat and cholesterol in order to lower our risk from dying from cardiovascular disease. During that same time we were encouraged to increase our consumption of carbohydrates in the form of grains and bakery products. We followed the Powers-That-Be’s advice and guess what? Our health has worsened. During the time we lowered our fat and cholesterol intake, we suffered with more obesity, diabetes, and heart disease.

Statin Drug Scandal: Cholesterol-lowering Drug Researchers Start Backtracking

The cholesterol-lowering statin drug empire continues to crumble. On February 15, 2015, the Sunday Express in the UK published a headline story stating that Oxford professor Dr. Rory Collins, whose research had been used to support putting millions of patients on statin drugs, was reassessing the data behind those studies for possible drug side effects. According to the Express: "Although the original research looked at the effect of statins on the heart and considered cancer risks it did not examine other side effects." This announcement by Dr. Collins is stunning, to say the least, and points to a massive cover-up and scandal related to statin drugs.

Statin Scam: People with Higher Cholesterol Live Longer than People with Low Cholesterol

Here is a fact that has been known for quite a long time, but is still news to many people: People with higher cholesterol levels live longer than people with lower cholesterol levels. The reason why this fact is not well-known to the general public is because it would put a huge dent into a $100 BILLION drug market for statin drugs. With approximately one out of every 4 Americans over the age of 50 currently prescribed a statin drug, a drug with very serious side effects, this is certainly one issue you should investigate yourself.

Study: Cholesterol-Lowering Statin Drugs Increase Bell’s Palsy

A study recently published in the international journal Drug Safety found a positive association between regular statin drug use and Bell's palsy, a neurologic disorder. This study confirms what Dr. Stephanie Seneff published back in 2009, showing how stain drugs used to lower cholesterol could be a main cause of Alzheimer's and other neurological diseases in old age.

Lawsuits Against Pfizer for Lipitor Could Reach 10,000

In a new Reuters’ story, Jessica Dye reports that U.S. women who say Lipitor gave them type-2 diabetes shot up from 56 to almost 1,000 court lawsuits in less than 5 months. The number of cases could ultimately reach 10,000 or more.

New Cholesterol Drug Approval to be Fast-tracked by FDA to Highest Bidder

Regeneron Pharmaceuticals Inc. and Sanofi SA are spending $67.5 million to purchase a voucher that will allow them to get the FDA to fast-track approval of a new class of cholesterol drugs, in hopes of beating a competitor to market.

Doctors Warning: Cholesterol Drug Risks Being Ignored

Top Irish surgeon warns statins raise chances of cancer and Parkinson's in otherwise healthy people. Sherif Sultan, of University College Hospital in Galway, warned that statin use can increase the risk of diabetes, cataracts and male impotence.

Thousands Sue for Damages Against Cholesterol Drugs as Big Pharma Defends Billion Dollar Industry

The $100 billion dollar cholesterol-lowering statin drug industry is under attack, as thousands of Americans are filing lawsuits against the manufacturers cholesterol-lowering drugs such as Lipitor.

UK Doctors Speak out on Dangers of Increase in Cholesterol-lowering Statin Drug Use

Millions of people over the age of 50 risk harming their health if they follow new NHS guidance telling them to take statins, leading doctors have warned the Health Secretary.